The following abstracts or summaries from speaker papers are available for download:
Corruption - a major barrier to access to medicines, by Dr Guitelle Baghdadi, Department of Medicines Policy and Standards, World Health Organisation.
> Download powerpoint presentation as PDF (973 kb)
Needs for specialized medical care (cardiac surgery) in the Ural Region and comparison with Western Europe, by Professor Thierry Carrel, Director, Department for Cardiovascular Surgery, University Hospital of Bern, Switzerland.
> Download as PDF (136 kb)
Two markets, two rules?, by Dr Yves Champey, Chair of the Board of Directors, Drugs for Neglected Diseases Initiative.
> Download as PDF (45 kb)
Industrialised countries vs. developing regions - two markets,
two rules? A regulator’s view, by Dr Petra Dörr, Head International Affairs, Swissmedic, Swiss Agency for Therapeutic Products, Switzerland.
> Download as PDF (40 kb)
Direct price negotiations instead of price fixing by the SFOPH, by Peter Fischer, CEO Visana, Switzerland.
> Download as PDF (80 kb)
Practical barriers to access to medication - the Coartem experience, by Dr Silvio Gabriel, Executive Vice President Malaria Initiatives, Novartis Pharma AG.
> Download powerpoint presentation as PDF (789 kb)
Availability and affordability - today's shortcomings, by Dr Karim Laouabdia-Sellami, Director, Campaign for Access to Essential Medicines, Medecins Sans Frontieres, Switzerland.
> Download as PDF (52 kb)
The right to health - a duty for whom?, by Professor Klaus M. Leisinger, President and CEO, Novartis Foundation for Sustainable Development.
> Download powerpoint presentation as PDF (385 kb)
Two markets, two rules?, by Dr Nicolaus Lorenz, President, Medicus Mundi Network Health for All, Switzerland.
> Download as PDF (52 kb)
Barriers to access to medication– the role of corruption and poverty, by Anne Lugon-Moulin, Deputy Head of Governance Division, Swiss Agency for Department for Development and Cooperation (SDC)
> Download as PDF (104 kb)
Main challenges of medication access, by MP Matsoso, Director, Department of Technical Cooperation for Essential Drugs and Traditional Medicine, WHO, Switzerland.
> Download as PDF (40 kb)
One pragmatic scenario: development of new clinical interventions to
fight poverty related diseases, by Pascoal Mocumbi, High Representative, European and Developing Countries Clinical Trials Partnership (EDCTP).
> Download as PDF (50 kb)
Barriers to access to medication. The example of AIDS, by Dr Fernando Pascual Martinez, Campaign for Access to Essential Medicines, Médecins sans Frontičres.
> Download as PDF (39 kb)
Scenarios for the future, by Professor Mark Pieth, President, Basel Institute on Governance.
> Download as PDF (39 kb)
Two markets, two rules?, by Dr Konji Sebati, Ambassador of South Africa to Switzerland.
> Download as PDF (40 kb)
Esperanza Medicines Foundation, by Dr Sacha Sidjanski, Head of Funder Relations, Esperanza Medicines Foundation, Switzerland.
> Download as PDF (44 kb)
How to finance research and equal access to medication - a Swiss perspective, by Vincenza Trivigno, Vice President, Economic Affairs, IPR, Interpharma.
> Download powerpoint presentation as PDF (156 kb)